March 2025 in “Journal of Dermatological Treatment” Cannabis users may need higher anesthetic doses during hair restoration surgery.
March 2025 in “Journal of Cosmetic Dermatology” Finasteride use may increase depression and suicide risk, especially at 1 mg, so monitoring is advised.
February 2025 in “PLoS ONE” Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.
February 2025 in “Lasers in Medical Science” Laser therapy shows promise for hair loss but lacks strong evidence due to limited studies.
January 2025 in “Expert Opinion on Pharmacotherapy” Dutasteride is more effective than finasteride for hair loss but may affect male fertility and should be used cautiously.
December 2024 in “Journal of Cosmetic Dermatology” Oral minoxidil rarely causes pericardial effusion, especially at low doses.
December 2024 in “Skin Appendage Disorders” Non-prescription products can help manage androgenic alopecia.
December 2024 in “Journal of Cosmetic Dermatology” Exosomes from platelet-rich plasma may help heal wounds but need more research for hair growth and skin use.
September 2024 in “Journal of Cosmetic Dermatology” Low-dose oral minoxidil can cause serious side effects like heart issues, so use the lowest effective dose.
September 2024 in “Journal of Dental Specialities” Combining PRP with micro-needling improves hair growth and thickness in treating hair loss.
June 2024 in “Journal of cosmetic dermatology” Dutasteride is the most studied alternative drug for androgenetic alopecia, but more high-quality research is needed.
May 2024 in “Journal of cosmetic dermatology” "Dutasteride 0.5 mg daily is the most effective treatment for male hair loss."
April 2024 in “Expert opinion on emerging drugs” New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.
April 2024 in “International Journal of Research Publication and Reviews” Alopecia areata causes hair loss with varied treatment responses and frequent relapses.
January 2024 in “Expert Opinion on Pharmacotherapy” Low-dose oral minoxidil is effective and safe for treating hair loss in men and women.
The document aims to compare the effectiveness of different single treatments for male pattern hair loss.
January 2024 in “Journal of Cosmetic Dermatology” Smoking increases the risk of male pattern hair loss.
January 2024 in “Skin appendage disorders” Oral finasteride seems more effective for hair loss in postmenopausal women, but more research is needed.
October 2023 in “Facial Plastic Surgery” The document concludes that hair transplant practices, especially Follicular Unit Excision, are continually improving with refined techniques and tools for better results.
The study aims to find the most effective treatments for male pattern baldness.
August 2023 in “Journal of Dermatological Treatment” Mesotherapy might improve hair growth, but more research is needed to confirm its safety and effectiveness.
June 2023 in “Journal of Cosmetic Dermatology” Finasteride 5mg daily is the most effective for female pattern hair loss, with higher doses of treatments generally more effective.
Cialis and Finasteride could be repurposed to treat aggressive melanoma.
February 2023 in “Indian Journal of Postgraduate Dermatology” The IADVL offers residents grants, scholarships, training, and learning resources for academic growth.
January 2023 in “Skin appendage disorders” Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.
January 2023 in “Skin appendage disorders” Minoxidil, platelet-rich plasma, and microneedling all help with pattern hair loss, but their effectiveness varies.
November 2022 in “Hair transplant forum international”
Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.
The document is about planning a review to assess if PRP alone is effective for treating hair loss in men and women.